Publications

Amaria, R., Knisely, A., Vining, D., Kopetz, S., Overman, M. J., Javle, M., Antonoff, M. B., Tzeng, C. W. D., Wolff, R. A., Pant, S., Lito, K., Rangel, K., Fellman, B., Yuan, Y., Lu, K. H., Sakellariou-Thompson, D., Haymaker, C. L., Forget, M. A., Hwu, P., … Jazaeri, A. A. (2024). Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma. Journal for Immunotherapy of Cancer, 12(2), e006822. https://doi.org/10.1136/JITC-2023-006822

Campbell, M. T., Balderrama-Brondani, V., Jimenez, C., Tamsen, G., Marcal, L. P., Varghese, J., Shah, A. Y., Long, J. P., Zhang, M., Ochieng, J., Haymaker, C., & Habra, M. A. (2024). Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial. The Lancet Oncology, 25(5), 649–657. https://doi.org/10.1016/S1470-2045(24)00095-0

Gordon, M. J., Feng, L., Strati, P., Lee, H. J., Hagemeister, F. B., Westin, J. R., Samaniego, F., Marques-Piubelli, M. L., Vega Vazquez, F., Parra Cuentas, E. R., Solis-Soto, L. M., Ma, W., Wang, J., Claret, L., Averill, B., Ibanez, K., Fayad, L. E., Flowers, C. R., Green, M. R., … Nastoupil, L. J. (2024). Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study. Cancer, 130(6), 876–885. https://doi.org/10.1002/CNCR.35114

Han, G., Sinjab, A., Rahal, Z., Lynch, A. M., Treekitkarnmongkol, W., Liu, Y., Serrano, A. G., Feng, J., Liang, K., Khan, K., Lu, W., Hernandez, S. D., Liu, Y., Cao, X., Dai, E., Pei, G., Hu, J., Abaya, C., Gomez-Bolanos, L. I., … Kadara, H. (2024). An atlas of epithelial cell states and plasticity in lung adenocarcinoma. Nature, 627(8004), 656–663. https://doi.org/10.1038/s41586-024-07113-9

He, S., Gubin, M. M., Rafei, H., Basar, R., Dede, M., Jiang, X., Liang, Q., Tan, Y., Kim, K., Gillison, M. L., Rezvani, K., Peng, W., Haymaker, C., Hernandez, S., Solis, L. M., Mohanty, V., & Chen, K. (2024). Elucidating immune-related gene transcriptional programs via factorization of large-scale RNA-profiles. IScience, 27(6), 110096. https://doi.org/10.1016/J.ISCI.2024.110096

How, J. A., Dang, M., Lee, S., Fellman, B., Westin, S. N., Sood, A. K., Fleming, N. D., Shafer, A., Yuan, Y., Liu, J., Zhao, L., Celestino, J., Hajek, R., Morgan, M. B., Parra, E. R., Laberiano Fernandez, C. D., Arrechedera, C. A., Solis Soto, L. M., Schmeler, K. M., … Jazaeri, A. A. (2025). Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial. Med, 6(1), 100494. https://doi.org/10.1016/J.MEDJ.2024.07.022

Hu, X., Zhu, B., Vokes, N., Fujimoto, J., Alvarez, F. R. R., Heeke, S., Moreira, A. L., Solis, L. M., Haymaker, C., Velcheti, V., Sterman, D. H., Pass, H. I., Cheng, C., Lee, J. J., Zhang, J., Wei, Z., Wu, J., Le, X., Ostrin, E., … Zhang, J. (2024). The evolution of lung adenocarcinoma precursors is associated with chromosomal instability and transition from innate to adaptive immune response/evasion. Research Square, rs.3.rs-4396272. https://doi.org/10.21203/RS.3.RS-4396272/V1

Kumar, G., Pandurengan, R. K., Parra, E. R., Kannan, K., & Haymaker, C. (2023). Spatial modelling of the tumor microenvironment from multiplex immunofluorescence images: methods and applications. Frontiers in Immunology, 14, 1288802. https://doi.org/10.3389/FIMMU.2023.1288802

Lubo, I., Hernandez, S., Wistuba, I. I., & Solis Soto, L. M. (2024). Novel Spatial Approaches to Dissect the Lung Cancer Immune Microenvironment. Cancers, 16(24). https://doi.org/10.3390/CANCERS16244145

Ludmir, E. B., Sherry, A. D., Fellman, B. M., Liu, S., Bathala, T., Haymaker, C., Medina-Rosales, M. N., Reuben, A., Holliday, E. B., Smith, G. L., Noticewala, S. S., Nicholas, S., Price, T. R., Martin-Paulpeter, R. M., Perles, L. A., Lee, S. S., Lee, M. S., Smaglo, B. G., Huey, R. W., … Tang, C. (2024). Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial. Journal of Clinical Oncology. https://doi.org/10.1200/JCO.24.00081/SUPPL_FILE/PROTOCOL_JCO.24.00081.PDF

Parra, E. R., Zhang, J., Duose, D. Y., Gonzalez-Kozlova, E., Redman, M. W., Chen, H., Manyam, G. C., Kumar, G., Zhang, J., Song, X., Lazcano, R., Marques-Piubelli, M. L., Laberiano-Fernandez, C., Rojas, F., Zhang, B., Taing, L., Jhaveri, A., Geisberg, J., Altreuter, J., … Haymaker, C. (2024). Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial. Clinical Cancer Research, 30(8), 1655. https://doi.org/10.1158/1078-0432.CCR-23-0251

Reddy, J. P., Sherry, A. D., Fellman, B., Liu, S., Bathala, T., Haymaker, C., Cohen, L., Smith, B. D., Ramirez, D., Shaitelman, S. F., Chun, S. G., Medina-Rosales, M., Teshome, M., Brewster, A., Barcenas, C. H., Reuben, A., Ghia, A. J., Ludmir, E. B., Weed, D., … Tang, C. (2024). Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 Trial. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/J.IJROBP.2024.10.030

Serrano, A. G., Rocha, P., Freitas Lima, C., Stewart, A., Zhang, B., Diao, L., Fujimoto, J., Cardnell, R. J., Lu, W., Khan, K., Sable, B., Ellison, A. R., Wistuba, I. I., Concannon, K. F., Halperin, D. M., Bogdan, C., Sircar, K., Zhang, M., Cargill, K., … Solis Soto, L. M. (2024). Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms. Npj Precision Oncology, 8(1), 268. https://doi.org/10.1038/S41698-024-00739-Y

Seth, S., Chen, R., Liu, Y., Fujimoto, J., Hong, L., Reuben, A., Varghese, S., Behrens, C., McDowell, T., Soto, L. S., Haymaker, C., Weissferdt, A., Kalhor, N., Wu, J., Le, X., Vokes, N. I., Cheng, C., Heymach, J. V., Gibbons, D. L., … Zhang, J. (2024). Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomes. Cancer Innovation, 3(3), e112. https://doi.org/10.1002/CAI2.112

Uzunparmak, B., Haymaker, C., Raso, G., Masciari, S., Wang, L., Lin, H., Gorur, A., Kirby, B., Cimo, A. M., Kennon, A., Ding, Q., Urschel, G., Yuan, Y., Feng, G., Rizvi, Y., Hussain, A., Zhu, C., Kim, P., Abbadessa, G., … Dumbrava, E. E. (2023). HER2-low expression in patients with advanced or metastatic solid tumors. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 34(11), 1035. https://doi.org/10.1016/J.ANNONC.2023.08.005